Search results
Aavas Financiers: Big-bang stake sale brewing as Kedaara, Partners Group explore full exit
CNBC Awaaz· 9 hours agoA mega stake sale is in the works at Aavas Financiers Ltd (formerly known as AU Housing Finance...
CoinDCX buys UAE crypto trading platform BitOasis - The Economic Times
The Economic Times· 11 hours agoIndian cryptocurrency exchange CoinDCX has acquired Dubai’s BitOasis for an undisclosed amount,...
Koo calls it a day; Paytm Bank, auditor lock horns
The Economic Times· 12 hours agoOnce touted as Indias response to Twitter, its curtains for homegrown microblogging app Koo. Details on this and more in todays ETtech Top 5.
Emcure Pharma IPO fully subscribed on Day 1 of offer
Indian Express· 12 hours agoThe issue, with a price band of Rs 960 to Rs 1,008 per share, will be open for public subscription till July 5. The IPO comprises fresh issuance of equity shares worth Rs 800 crore and an offer ...
MLB Private Equity Ownership Rules: Can PE Have Stakes in Teams?
Sportico· 13 hours agoPrivate equity is as American as baseball and apple pie. PE as we know it developed stateside after...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 15 hours agoThe IPO consists of a new issue of equity shares valued at ₹800 crore and an offer of sale (OFS) by...
Bain’s India lender plans to double portfolio ahead of listing
CNBC Awaaz· 16 hours agoTyger Capital Pvt Ltd., the Indian shadow lender Bain Capital bought from the Adani Group, is...
Emcure Pharmaceuticals IPO opens today | India Infoline
India Infoline· 18 hours agoThe IPO, backed by Bain Capital, has a price band set between ₹960 and ₹1,008 per share and will close on July 5.
Bain Capital-backed Emcure Pharma mobilises Rs 583 Cr from anchor investors
YourStory· 20 hours agoThe anchor book includes HDFC Mutual Fund, ICICI Prudential MF, SBI MF, Nippon India MF, Abu Dhabi Investment Authority, Goldman Sachs Asset Management, Nomura, HDFC Life Insurance Company, ...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? - The Economic Times
The Economic Times· 21 hours agoEmcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity...